Recent studies have also shown that administration of the HO-1 inducer hemin significantly alleviates steatosis, inflammation, and fibrosis in mice fed an MCD diet, while also reducing serum ALT and AST levels by inhibiting both canonical and non-canonical Wnt signaling pathways [55]. Here, HMOX1 is linked to steatosis.